We’re happy to announce the launch of Biosurance® PH. A brand new product which addresses the unique set of risks faced by pharmaceutical companies, from drug designers and licence holders to manufacturers, wholesalers and retailers.
Many traditional insurance policies have not adequately addressed the real risks faced by these companies.
Recognising this, we’ve introduced genuinely new and much needed capacity into the market without the restrictions that many reinsurers usually insist upon. This means we have a great deal of flexibility in our approach in areas like drug exclusion lists, USA domiciled manufacturing activities of non-USA parent companies and USA exports.
Biosurance® PH covers companies with revenues of up to £500m. In addition, the policy offers public, pollution and products liability limits of £15m and employers’ liability limits of £10m. As brokers have come to expect from us, Biosurance® PH delivers a streamlined application form and clear policy wording.